ARCHIVES

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Klausner, Nathan Discuss Challenge of Cancer Research In the “Post-Genome World”

January 15, 1999

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

May 31, 1996

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995

Mammography’s Best Role Is Screening, Kopans Assert

March 18, 1994

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

June 29, 2012